Atypical chemokine receptors predict lymph node metastasis and prognosis in patients with cervical squamous cell cancer

Gynecologic Oncology

Volumn 130, Issue 1, 2013, Pages 181-187

  Hou, Teng ^a   Liang, Dongxia ^a   Xu, Liqun ^a   Huang, Xin ^a   Huang, Yongwen ^a   Zhang, Yanna ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

Atypical chemokine receptors; CCX CKR; Cervical squamous cell carcinoma; D6; DARC; Prognosis

Indexed keywords

CD45 ANTIGEN; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; MONOCYTE CHEMOTACTIC PROTEIN 1;

ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; CERVICAL SQUAMOUS CELL CANCER; FEMALE; FOLLOW UP; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECURRENCE FREE SURVIVAL; SQUAMOUS CELL CARCINOMA; TUMOR RECURRENCE; TUMOR VOLUME; UTERINE CERVIX CARCINOMA IN SITU;

ADULT; CARCINOMA, SQUAMOUS CELL; CHEMOKINE CCL19; CHEMOKINE CCL2; DISEASE-FREE SURVIVAL; DUFFY BLOOD-GROUP SYSTEM; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; LYMPHATIC METASTASIS; MULTIVARIATE ANALYSIS; PARAFFIN EMBEDDING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RECEPTORS, CCR; RECEPTORS, CCR10; RECEPTORS, CELL SURFACE; RECEPTORS, CHEMOKINE; REGRESSION ANALYSIS; UTERINE CERVICAL NEOPLASMS;

EID: 84879085241     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2013.04.015     Document Type: Article

References (34)

1. C.M. Martin, K. Astbury, L. McEvoy, S. O'Toole, O. Sheils, and J.J. O'Leary Gene expression profiling in cervical cancer: identification of novel markers for disease diagnosis and therapy Methods Mol Biol 511 2009 333 359
2. S. Polterauer, L. Hefler, V. Seebacher, J. Rahhal, C. Tempfer, and R. Horvat The impact of lymph node density on survival of cervical cancer patients Br J Cancer 103 2010 613 616
3. K. Shiromizu, T. Kasamatsu, T. Honma, K. Matsumoto, T. Shirai, and M. Takahashi Clinicopathological study of recurrent uterine cervical squamous-cell carcinoma J Obstet Gynaecol Res 25 1999 395 399
4. T.W. Burke, W.J. Hoskins, P.B. Heller, M.C. Shen, E.B. Weiser, and R.C. Park Clinical patterns of tumor recurrence after radical hysterectomy in stage IB cervical carcinoma Obstet Gynecol 69 1987 382 385
5. M.E. Potter, R.D. Alvarez, F.L. Gay, H.M. Shingleton, S.J. Soong, and K.D. Hatch Optimal therapy for pelvic recurrence after radical hysterectomy for early-stage cervical cancer Gynecol Oncol 37 1990 74 77
6. A. Mantovani, B. Savino, M. Locati, L. Zammataro, P. Allavena, and R. Bonecchi The chemokine system in cancer biology and therapy Cytokine Growth Factor Rev 21 2010 27 39
7. M.H. Ulvmar, E. Hub, and A. Rot Atypical chemokine receptors Exp Cell Res 317 2011 556 568
8. S. Segerer, J. Jedlicka, and R.P. Wuthrich Atypical chemokine receptors in renal inflammation Nephron Exp Nephrol 115 2010 e89 e95
9. R. Nibbs, G. Graham, and A. Rot Chemokines on the move: control by the chemokine "interceptors" Duffy blood group antigen and D6 Semin Immunol 15 2003 287 294
10. G.J. Graham, M. Locati, A. Mantovani, A. Rot, and M. Thelen The biochemistry and biology of the atypical chemokine receptors Immunol Lett 145 2012 30 38
11. N.F. Neel, E. Schutyser, J. Sai, G.H. Fan, and A. Richmond Chemokine receptor internalization and intracellular trafficking Cytokine Growth Factor Rev 16 2005 637 658
12. R.J. Nibbs, S.M. Wylie, J. Yang, N.R. Landau, and G.J. Graham Cloning and characterization of a novel promiscuous human beta-chemokine receptor D6 J Biol Chem 272 1997 32078 32083
13. V.L. Schweickart, A. Epp, C.J. Raport, and P.W. Gray CCR11 is a functional receptor for the monocyte chemoattractant protein family of chemokines J Biol Chem 276 2001 856
14. A.S. Payne, and L.A. Cornelius The role of chemokines in melanoma tumor growth and metastasis J Invest Dermatol 118 2002 915 922
15. I. Comerford, R.J. Nibbs, W. Litchfield, M. Bunting, Y. Harata-Lee, and S. Haylock-Jacobs The atypical chemokine receptor CCX-CKR scavenges homeostatic chemokines in circulation and tissues and suppresses Th17 responses Blood 116 2010 4130 4140
16. F. Balkwill Chemokine biology in cancer Semin Immunol 15 2003 49 55
17. J. Catusse, M. Leick, M. Groch, D.J. Clark, M.V. Buchner, and K. Zirlik Role of the atypical chemoattractant receptor CRAM in regulating CCL19 induced CCR7 responses in B-cell chronic lymphocytic leukemia Mol Cancer 9 2010 297
18. K. Milne, R.O. Barnes, A. Girardin, M.A. Mawer, N.J. Nesslinger, and A. Ng Tumor-infiltrating T cells correlate with NY-ESO-1-specific autoantibodies in ovarian cancer PLoS One 3 2008 e3409
19. F.B. Mayr, A.O. Spiel, J.M. Leitner, C. Firbas, J. Schnee, and J. Hilbert Influence of the Duffy antigen on pharmacokinetics and pharmacodynamics of recombinant monocyte chemoattractant protein (MCP-1, CCL-2) in vivo Int J Immunopathol Pharmacol 22 2009 615 625
20. M. Iiizumi, S. Bandyopadhyay, and K. Watabe Interaction of Duffy antigen receptor for chemokines and KAI1: a critical step in metastasis suppression Cancer Res 67 2007 1411 1414
21. M.L. Berres, C. Trautwein, M.M. Zaldivar, P. Schmitz, K. Pauels, and S.A. Lira The chemokine scavenging receptor D6 limits acute toxic liver injury in vivo Biol Chem 390 2009 1039 1045
22. J. Wang, Z.L. Ou, Y.F. Hou, J.M. Luo, Z.Z. Shen, and J. Ding Enhanced expression of Duffy antigen receptor for chemokines by breast cancer cells attenuates growth and metastasis potential Oncogene 25 2006 7201 7211
23. C.D. Madsen, and E. Sahai Cancer dissemination-lessons from leukocytes Dev Cell 19 2010 13 26
24. I. Comerford, S. Milasta, V. Morrow, G. Milligan, and R. Nibbs The chemokine receptor CCX-CKR mediates effective scavenging of CCL19 in vitro Eur J Immunol 36 2006 1904 1916
25. I.V. Iancu, A. Botezatu, C.D. Goia-Rusanu, A. Stanescu, I. Huica, and E. Nistor TGF-beta signalling pathway factors in HPV-induced cervical lesions Roum Arch Microbiol Immunol 69 2010 113 118
26. C.S. McKimmie, A.R. Fraser, C. Hansell, L. Gutierrez, S. Philipsen, and L. Connell Hemopoietic cell expression of the chemokine decoy receptor D6 is dynamic and regulated by GATA1 J Immunol 181 2008 8171 8181
27. X.H. Zeng, Z.L. Ou, K.D. Yu, L.Y. Feng, W.J. Yin, and J. Li Coexpression of atypical chemokine binders (ACBs) in breast cancer predicts better outcomes Breast Cancer Res Treat 125 2011 715 727
28. F.Y. Wu, Z.L. Ou, L.Y. Feng, J.M. Luo, L.P. Wang, and Z.Z. Shen Chemokine decoy receptor d6 plays a negative role in human breast cancer Mol Cancer Res 6 2008 1276 1288
29. A.O. Watts, F. Verkaar, M.M. van der Lee, C.A. Timmerman, M. Kuijer, and J. van Offenbeek Beta-arrestin recruitment and G protein signaling by the atypical human chemokine decoy receptor CCX-CKR J Biol Chem 288 2013 7169 7181
30. L.Y. Feng, Z.L. Ou, F.Y. Wu, Z.Z. Shen, and Z.M. Shao Involvement of a novel chemokine decoy receptor CCX-CKR in breast cancer growth, metastasis and patient survival Clin Cancer Res 15 2009 2962 2970
31. G. Sun, Y. Wang, Y. Zhu, C. Huang, and Q. Ji Duffy antigen receptor for chemokines in laryngeal squamous cell carcinoma as a negative regulator Acta Otolaryngol 131 2011 197 203
32. S. Bandyopadhyay, R. Zhan, A. Chaudhuri, M. Watabe, S.K. Pai, and S. Hirota Interaction of KAI1 on tumor cells with DARC on vascular endothelium leads to metastasis suppression Nat Med 12 2006 933 938
33. C.L. Addison, J.A. Belperio, M.D. Burdick, and R.M. Strieter Overexpression of the Duffy antigen receptor for chemokines (DARC) by NSCLC tumor cells results in increased tumor necrosis BMC Cancer 4 2004 28
34. X. Cheng, and M.C. Hung Regulation of breast cancer metastasis by atypical chemokine receptors Clin Cancer Res 15 2009 2951 2953